Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

INTRODUCTION: Circulating tumor cells (CTCs) are detectable in most cancer patients and they can meet an existing medical need to monitor cancer patients during a course of treatment and to help determine recurrent disease. CTCs are rarely found in the blood of cancer patients and enrichment is nece...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Glenn, Herrler, Michael, Burgess, David, Manna, Edward, Krag, David, Burke, Julian F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575542/
https://www.ncbi.nlm.nih.gov/pubmed/18687126
http://dx.doi.org/10.1186/bcr2131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575542/
https://www.ncbi.nlm.nih.gov/pubmed/18687126
http://dx.doi.org/10.1186/bcr2131

Ejemplares similares